Sign in or register to see full information and data.

Studies / CAVD 290


Study information

Grant Affiliation:Ho: Enhancing Innate Immune Activation
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2007-09-05
Study Made Public:2011-02-25


Screen for broadly neutralizing sera among Dr. Bruce Walker’s Massachusetts General Hospital HIV+ Patient Cohort in Boston [Original Study Title: Walker 1 and Walker 2]


CAVD 290 is an immunogenicity study to evaluate and characterize the neutralization activity of broadly neutralizing antibodies from humans in HIV controllers.


No Products used in study

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.